Nori Appointed to Cornell Department of Radiation Oncology

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

FLUSHING, NY--The New York Hospital-Cornell Medical Center has appointed Dattatreyudu Nori, MD, a pioneer in the subspecialty of brachytherapy, to the position of professor and chairman of the Department of Radiation Oncology.

FLUSHING, NY--The New York Hospital-Cornell Medical Center hasappointed Dattatreyudu Nori, MD, a pioneer in the subspecialtyof brachytherapy, to the position of professor and chairman ofthe Department of Radiation Oncology.

Dr. Nori will remain as professor and chairman of the Departmentof Radiation Oncology and director of Oncology at The New YorkHospital Medical Center of Queens, which is affiliated with theNew York Hospital-Cornell Medical Center and is a member of theNew York Hospital Care Network.

In his new position, Dr. Nori will direct the department's clinicalactivities, its research program, and the training of residentphysicians in radiation oncology.

He will also oversee the administration of the radiation oncologyprograms for the New York Hospital Care Network's 13 member hospitals.The combined network program will be one of the largest in thecountry, providing state-of-the-art radiation treatments to morethan 3,000 new patients each year.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content